Key facts
- This page summarizes Rolf Stangl's Form 4 filing for Pactiv Evergreen Inc. (PTVE).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 01 Apr 2025, 12:08.
Rolf Stangl - 01 Apr 2025 Form 4 Insider Report for Pactiv Evergreen Inc. (PTVE)
- Reporting relationship
- Director
- Issuer ticker
- PTVE
- Reported as of
- 01 Apr 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 01 Apr 2025, 12:08:54 UTC
- Prior SEC filing
- 11 Feb 2025
- Next SEC filing
- 24 Apr 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Tyler T. Rosenbaum, by Power of Attorney
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Rolf Stangl filed Form 4 for Pactiv Evergreen Inc. (PTVE) on 01 Apr 2025.
Change
- Previous filing in this sequence was filed on 11 Feb 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PTVE
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +161
- Change %
- +0.18%
- Price
- $0.000000
- Shares after
- 91,766
- Date
- 01 Apr 2025
- Ownership
- Direct
- Footnotes
- F1
PTVE
transaction
Common Stock
Disposed to Issuer
- Transaction value
- Shares
- -91,766
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 01 Apr 2025
- Ownership
- Direct
- Footnotes
- F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Rolf Stangl is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 3 footnotes
Footnote F1
Represents additional shares acquired by the reporting person in connection with the settlement of dividend equivalent rights upon the accelerated vesting of the reporting person's outstanding restricted stock units ("RSUs"), as described below.
Footnote F2
On April 1, 2025, pursuant to the Agreement and Plan of Merger dated as of December 9, 2024 (the "Merger Agreement"), by and among the Issuer, Novolex Holdings, LLC (the "Parent") and Alpha Lion Sub, Inc. ("Merger Sub"), Merger Sub merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a wholly-owned subsidiary of the Parent.
Footnote F3
Pursuant to the Merger Agreement, each share of the Issuer's common stock and each unvested RSU, including any dividend equivalent rights accrued thereon, was canceled and converted into the right to receive $18.00 in cash, without interest.